No abstract available
MeSH terms
-
Adalimumab
-
Antibodies, Monoclonal / administration & dosage*
-
Antibodies, Monoclonal / adverse effects*
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents / administration & dosage*
-
Antineoplastic Agents / adverse effects*
-
Humans
-
Immunosuppression Therapy / adverse effects*
-
Infliximab
-
Liver Neoplasms / mortality
-
Liver Neoplasms / physiopathology*
-
Liver Neoplasms / therapy*
-
Lymphoma, T-Cell / mortality
-
Lymphoma, T-Cell / physiopathology*
-
Lymphoma, T-Cell / therapy*
-
Male
-
Splenic Neoplasms / mortality
-
Splenic Neoplasms / physiopathology*
-
Splenic Neoplasms / therapy*
-
Tumor Necrosis Factor-alpha* / antagonists & inhibitors
-
Young Adult
Substances
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents
-
Tumor Necrosis Factor-alpha
-
Infliximab
-
Adalimumab